'Pai 1' diaporamas de présentation

Haemostatic Challenges of Haemopoietic Stem Cell Transplantation

Haemostatic Challenges of Haemopoietic Stem Cell Transplantation. Omolade Awodu FMCPath July 2013. O bjectives. Factors contributing to haemostatic challenges in HSCT Preventing haemostatic challenges Tackling Haemostatic Challenges. 2. My Talk. Overview of normal haemostasis

846 views • 66 slides

Plasmin

Plasminogen activators (t-PA, u-PA ). Plasminogen activator inhibitors (PAI). Plasminogen activator inhibitors (PAI). ProMMP. ECM. Plasminogen. Plasmin. MMP. Circulation. Fibrin degradation products. Fibrin. February 19, 2004. Plasminogen activator inhibitors.

828 views • 44 slides

TAILORED THERAPIES: PROGNOSTIC & PREDICTIVE FACTORS

BELGIAN BREAST MEETING 2008 October 4-5, 2008. TAILORED THERAPIES: PROGNOSTIC & PREDICTIVE FACTORS. F. Cardoso, MD Jules Bordet Institute, Brussels, Belgium. THE GOALS OF TREATMENT TAILORING. INDIVIDUALIZE TREATMENT. AVOID UNDER- AND OVER-TREATMENT. New/better PREDICTIVE FACTORS.

580 views • 43 slides

544 views • 36 slides

Characterization of antithrombin -specific RNA aptamers for use in anticoagulant therapy

Characterization of antithrombin -specific RNA aptamers for use in anticoagulant therapy. Yolanda M. Fortenberry, Ph.D. Hematology 2014 Conference Johns Hopkins University School of Medicine. What are aptamers?. Synthetic ssDNA or RNA molecules.

534 views • 35 slides

Dr. S. Arefi Assistant Prof. , Affiliated researcher

Evidence-based guidelines for the investigation of recurrent miscarriage ESHRE Special Interest Group for Early Pregnancy (SIGEP). Dr. S. Arefi Assistant Prof. , Affiliated researcher. Common Case. ??? ? ???? 3 ??? ??? ?? ?????? ???? ???. ????? ?? ??? ??? ???????? ???? 9-10 ???? ????? ???.

398 views • 31 slides

Nonglycemic Effects of Thiazolidinediones

383 views • 30 slides

Crit Care Med 2006 March Vol.34 p871-877 Ri ???

458 views • 30 slides

Nonglycemic Effects of Thiazolidinediones

404 views • 30 slides

6 Atherothrombosis and the Metabolic Syndrome

6 Atherothrombosis and the Metabolic Syndrome. Emma J. Dunn and Peter J. Grant. Introduction. The metabolic syndrome- also known as the insulin resistance syndrome- associated with a cluster of abnormalities including obesity, hypertention, glucose intolerance and dyslipidaemia.

571 views • 29 slides

What are the serpins?

What are the serpins?. It is a family of proteins characterised by a common molecular architecture Most of the serpins are ser ine p rotease in hibitors, but some of them have other functions Today, more than 500 serpins have been identified in animals, plants, bacteria and viruses.

507 views • 28 slides

Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

Long-term Voluntary Exercise Decreased the Incidence of Apoplexy and Elongated the Lifespan through Activation of eNOS and Inhibition of Inflammatory Signaling Pathway in Stroke-Prone SHR. Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

441 views • 22 slides

Prevention of Coronary Artery Disease PAS-880

Prevention of Coronary Artery Disease PAS-880. Robert D. Hadley, PhD, PA-C July 19, 2001. What is CAD?. Coronary artery insufficiency and blockage, resulting in angina and MI CAD is one facet of systemic vascular disease

475 views • 22 slides

Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

Long-term Voluntary Exercise Decreased the Incidence of Apoplexy and Elongated the Lifespan through Activation of eNOS and Inhibition of Inflammatory Signaling Pathway in Stroke-Prone SHR. Hideaki Higashino , Atsuko Niwa, Masaki Tabuchi, Kana Ooshima, and Hiroshi Sakaue

315 views • 22 slides

970 views • 21 slides

Thrombotic Complications in Hematologic Malignancies

Thrombotic Complications in Hematologic Malignancies. Hau C. Kwaan, MD, FRCP Marjorie C Barnett Professor of Hematology-Oncology Division of Hematology and Oncology Northwestern University Feinberg School of Medicine Chicago , IL, U.S.A.

339 views • 16 slides

Thrombotic Complications in Hematologic Malignancies

Thrombotic Complications in Hematologic Malignancies. Hau C. Kwaan, MD, FRCP Marjorie C Barnett Professor of Hematology-Oncology Division of Hematology and Oncology Northwestern University Feinberg School of Medicine Chicago , IL, U.S.A.

351 views • 16 slides

???????????? (fibrinolytic system)

???????????? (fibrinolytic system). ????? ?????????????????????? ( ? ) ??????????. PLG. PL. ?. Fb(Fg). ?????????????. 1. ?????????? ( t-PA ) ?. ??? ? ???????????????? ??????????? 5ug/L ? ??? ???. PL ? UK. ????? PLG ? PLG PL. 2. ??????????? (U-PA) ?

399 views • 15 slides

The Evaluation of Cardiometabolic Risk in the offsprings of the type 2 diabetic patients

The Evaluation of Cardiometabolic Risk in the offsprings of the type 2 diabetic patients. Ankara E?itim ve Ara?t?rma Hastanesi Endokrinoloji ve Metabolizma Hastal?klar? Klini?i. Dr.Yavuz Selim Demir. Aim -----------------------------------------------------------

231 views • 10 slides

Vascular Effects of Insulin: Implications for Hyperglycemia Management

Vascular Effects of Insulin: Implications for Hyperglycemia Management. Potential beneficial effects of insulin. Anti-inflammatory ?NF- ? B ?MCP-1 ?ICAM-1 ?CRP ?I ? B. Antithrombotic ?TF ?PAI-1. Mechanistic benefits of insulin. Vasodilatory + Platelet inhibitory

234 views • 9 slides